Systemic Lupus Erythematosus

Key Points

  • Systemic lupus erythematosus (SLE) is a chronic autoimmune disease with multisystem inflammation and variable severity.
  • Disease activity often alternates between flare-ups and remissions.
  • Common triggers include stress, infection, sunlight exposure, surgery, pregnancy-related physiologic stress, and some medications.
  • Assessment spans skin, musculoskeletal, renal, cardiopulmonary, neurologic, ocular, gastrointestinal, and psychosocial findings.
  • Nursing priorities include medication adherence, flare-prevention teaching, infection-risk reduction, and psychosocial support.

Pathophysiology

In SLE, immune regulation fails and autoantibodies target healthy tissues. This self-directed immune activity causes inflammation and tissue injury across multiple organ systems.

SLE is characterized by fluctuating activity. Periods of exacerbation can be followed by partial or full symptom reduction, so ongoing trend-based assessment is required even when symptoms temporarily improve.

Risk and Pattern Overview

  • Higher prevalence is reported in women, especially ages 15 to 40.
  • Higher prevalence and risk are reported in African American, Asian, and Native American populations.
  • Typical symptom patterns include fatigue, arthritis, and malar (butterfly) rash, but manifestations vary widely between clients.
  • Additional vascular-pattern findings may include Raynaud syndrome with cold-induced pallor or cyanosis of fingers.

Nursing Assessment

NCLEX Focus

Priority assessment identifies active flare severity, organ-threat cues, and complication risk while correlating findings with laboratory trends.

  • Assess for skin findings, including photosensitive reactions, malar rash, and discoid lesions.
  • Assess musculoskeletal findings, including arthralgia, joint swelling, and morning stiffness.
  • Screen for cardiovascular and pulmonary involvement such as pericarditis, endocarditis, pleuritis, and pleural effusion.
  • Monitor renal signs (proteinuria, hematuria) as potential evidence of kidney inflammation.
  • Assess neurologic and cognitive changes, including headache, memory impairment, neuropathic symptoms, or cognitive dysfunction.
  • Assess for severe neurologic complications such as migraine-pattern headache, seizure activity, or major neuropsychiatric changes.
  • Assess ocular, gastrointestinal, and psychological manifestations such as vision changes, eye pain, abdominal symptoms, anxiety, depression, or mood change.
  • Monitor hematologic compromise (anemia, thrombocytopenia, leukopenia trends), lymphatic/splenic enlargement cues, and high-risk pregnancy complications when applicable.
  • Review inflammatory and autoimmune laboratory trends used in diagnosis and monitoring, including ANA, complement C3/C4, ESR, and CRP.

Nursing Diagnoses and Outcomes

Common nursing diagnosis themes include chronic pain, fatigue, risk for impaired skin integrity, and disturbed body image.

Sample measurable outcomes include:

  • Client verbalizes nonpharmacologic pain-management strategies by end of teaching.
  • Client reports improved energy after medication-plan implementation.
  • Client verbalizes skin-protection techniques to reduce breakdown risk.
  • Client verbalizes feelings and coping strategies for body-image changes within the planned interval.

Nursing Interventions

  • Reinforce medication adherence and teach purpose, expected benefit, and monitoring needs for each prescribed class.
  • Provide structured health teaching on sun protection, balanced nutrition, exercise, and trigger avoidance.
  • Teach infection-prevention behaviors for clients on immunosuppressive therapy, including hand hygiene and avoidance of known infectious exposures.
  • Use therapeutic communication to support coping with chronic disease burden and unpredictable symptom cycles.
  • Facilitate support-group or counseling referral when persistent mood or adjustment concerns are present.
  • Reassess outcomes after interventions, new laboratory data, and interprofessional care-plan updates, then revise the care plan if outcomes are partially met or unmet.

Pharmacology

Drug ClassExamplesKey Nursing Considerations
NSAIDsibuprofen, naproxenSymptom relief for mild inflammatory and musculoskeletal pain patterns.
CorticosteroidsprednisoneUsed for severe or organ-threatening inflammation; monitor adverse effects closely.
Immunosuppressantsazathioprine, methotrexate, mycophenolate mofetilSuppress disease activity in severe or refractory cases; increase infection vigilance.
Antimalarialshydroxychloroquine, chloroquineSupport control of rash, joint symptoms, and fatigue and help reduce flare frequency.
Biologic response modifiersbelimumab, rituximabTarget immune pathways in selected cases with ongoing disease activity.
Calcineurin inhibitorstacrolimus, cyclosporineAdditional immune-suppression option in selected clients.

Clinical Judgment Application

Clinical Scenario

A client with known SLE reports new fatigue, worsening joint pain, facial rash after sun exposure, and increasing proteinuria.

  • Recognize Cues: Multisystem findings suggest active inflammatory flare with renal risk.
  • Analyze Cues: Trigger exposure and trend changes support flare progression.
  • Prioritize Hypotheses: Priority is limiting organ injury while controlling active symptoms and infection risk.
  • Generate Solutions: Reinforce treatment adherence, trigger avoidance, and close monitoring of labs and symptom progression.
  • Take Action: Implement teaching, coordinate interprofessional follow-up, and escalate worsening organ-threat findings.
  • Evaluate Outcomes: Symptoms stabilize, lab trends improve, and the client demonstrates self-management behaviors.

Self-Check

  1. Which assessment findings suggest SLE flare progression versus stable remission?
  2. Why do renal findings like proteinuria and hematuria require close trend-based monitoring?
  3. Which teaching points most reduce flare triggers and immunosuppression-related complications?